Skip to content
TrialScanner

NCT03902522

PRO 140 in Treatment-Experienced HIV-1 Subjects

Phase 2/Phase 3CompletedCYDYLead

Registry record

Lead sponsor
CytoDyn, Inc.
Conditions
HIV-1-infection
Primary completion
May 18, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03902522 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03902522: PRO 140 in Treatment-Experien... | TrialScanner